Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DOF Subsea awarded multiple contracts by Petrobras

DOF Subsea is proud to announce four new contracts with Petrobras. The contracts include work within our core service lines for Survey and Inspection. At least three vessels from the DOF fleet shall be mobilised to perform flexible pipeline, risers and subsea equipment inspection in Campos Basin, Santos Basin, Marlin Field and Espírito Santos Basin. The contracts are worth more than USD 110 million with planned commencement in Q4 2020 and estimated to be performed within 550 days. Mons S Aase, CEO, DOF Subsea said, “I am very pleased for these awards securing utilisation for our

Optomed ’s financial reporting in 2021

Optomed Plc         Stock Exchange Release    27 August 2020 at 9.15, Helsinki Optomed’s financial reporting in 2021 Optomed Plc will release its Financial Statement Bulletin, Half-Year Financial Report and Interim Reports in 2021 as follows: · Financial Statement Bulletin for 1 January – 31 December 2020, 18 February 2021 · Interim Report for 1 January – 31 March 2021, 6 May 2021 · Half-Year Financial Report for 1 January – 30 June 2021, 5 August 2021 · Interim Report for 1 January – 30 September 2021, 4 November 2021 Annual Report 2020, which includes the company’s

PHI granted patent on synthetic antibodies in the U.S.

Phase Holographic Imaging AB (PHI) announces today that the Company has been granted a patent (US10730986B2 ) on synthetic antibodies from the United States Patent and Trademark Office (USPTO). PHI submitted the patent application "Molecularly Imprinted Polymers" together with Germany’s federal institute for materials research (BAM) to the USPTO on November 20, 2017."The approval of the patent in the U.S. marks a significant milestone for the

American Shipping Company ASA - Ex-dividend today

Lysaker, 27 August 2020, Ex-dividend today Reference is made to the Company's Q2 2020 report, regarding the Board's authorization to pay a quarterly dividend of USD 0.10 per share to the shareholders of AMSC on record as of 28 August 2020.  The shares in American Shipping Company ASA will be traded ex dividend USD 0.10 as from today, 27 August 2020.  The NOK amount per share will be 0.8958 and will be paid on or about 7 Septmeber 2020.  The dividend is classified as a return of paid in capital. *** About American Shipping Company ASA: Established in 2005 and listed on the OSE,

Flexion Mobile launches Tabou Stories in its key channels

LONDON, 27th of August, 2020 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has launched Tabou Stories: Love Episodes from Nanobit. Nanobit is one of the leading developers of Interactive story based games, a genre that has become very popular. Tabou Stories was launched in Google Play in February and has rapidly grown its user base and revenues. This is the 3rd title that Flexion distributes from Nanobit. The game is now live in Flexion's core channels, Samsung, Huawei and Amazon. "In just two weeks we have launched 3 new games and I

Half year interim report Frill Holding AB

STOCKHOLM, Thu, August 27, 2020 08.00 CETFrill Holding AB publishes half year interim report January to June 2020. Financial overview · Net sales for the period amounted to 1 173 TSEK (1 144) · EBIT for the period amounted to –5 837 TSEK (-8 673) · Equity at the end of the period amounted to 37 257 TSEK (24 943) · Earnings per share totalled SEK -0.2 (-0.4) · Cash flow from operating activities amounted to -4 936 TSEK (-7 615) · Cash and cash equivalents at the end of the period amounted to 862 TSEK (4 108) · In July 2020, the company received 15 155 TSEK (before

Tradedoubler Interim Report January - June 2020

The second quarter April - June 2020 · Net sales amounted to SEK 287 M (289) a decrease of -1% or 0% adjusted for changes in exchange rates compared to the same period last year. · Gross profit was SEK 64 M (65), a decrease of -1% and -1% adjusted for changes in exchange rates. Gross margin was 22.4% (22.5). · Operating costs excluding depreciation and change related items were SEK 50M (56), a decrease of -11%. · EBITDA amounted to SEK 14 M (7). Adjusted for change related items, EBITDA was SEK 14 M (9). · Capitalised expenses for product development were SEK 6 M (5). ·

Herantis Pharma Plc Announces CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months

Data on exploratory efficacy endpoints continue to show a promising biological signal in some patientsHerantis Pharma PlcCompany release August 27, 2020 at 9:00 AM Eastern European Summer Time Herantis Pharma Plc (“Herantis” or “Company”) announced today that its novel drug candidate, Cerebral Dopamine Neurotrophic Factor (CDNF) for the treatment of Parkinson’s disease (PD), has successfully achieved its primary endpoint of safety and tolerability in a 12 month Phase I-II study in patients with moderate disease. CDNF is a multi- modal, natural protein that has shown potential to slow

Skanska divests multifamily housing portfolio in Skåne, Sweden, to KPA Pension for about SEK 1.5 billion

Skanska has sold a portfolio of five multifamily projects in Skåne, Sweden, for a total of approximately SEK 1.5 billion. The investor is KPA Pension. The transaction will be recognized by Skanska Sweden in the business stream residential development in the third quarter of 2020.The transaction relates to projects in Malmö, Lund, Helsingborg and Ängelholm that are being developed and constructed by Skanska Sweden. The portfolio includes a range of products, from townhouse-style condominiums to buildings eight stories tall totaling approximately 600 apartments. All projects are being

Polygiene AB (publ.) Interim Report 1 April–30 June 2020

ViralOff[®] success, record number of new agreementsQ2 in brief · Positive growth due to increased net sales by 37.4 % during the quarter compared to the same period last year and amounted to MSEK 17.3 (12.6). · The operating profit/loss before tax for the period has improved compared to the same period last year and amounted to MSEK -1.1 (-5.4). · The gross margin has decreased at 70.3 (72.1) %. · Cash flow remained unchanged of the second quarter, MSEK 0.0 (-2.2). Events during Q2 2020 (Aril-June) · In connection with the launch of ViralOff the company strengthens

Clavister Q2 2020: All-time High Order Intake and Positive Operating Cash-flow

August 27, 2020, Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its second quarterly 2020 interim report today.  “Our second quarter of 2020 saw record order intake, important customer contract wins as well as some operational impacts of the Covid-19 pandemic. Positive operating cash-flow in the period was mainly attributed to improved invoiced sales, higher gross margins and cost and cash management. Our order intake for the second quarter increased by 49% (adjusted for China) and ended at an all-time high level of 55 MSEK. The

IRRAS AB publishes Interim Report for the period January to June 2020

Market begins to brighten after lockdowns “In the second quarter, IRRAS made several advances in the ongoing commercialization of IRRAflow and Hummingbird, despite the fact that the extensive covid-19 restrictions were a highly disruptive and delaying factor. The covid-19 pandemic continues to limit our commercial activities and access to hospitals in countries around the world. However, compared with the widespread lockdowns in the second quarter, the situation is starting to improve. At the beginning of the third quarter, for the first time since the lockdowns came into force, we

Notice of Half-Year Report

Faron Pharmaceuticals Ltd (“Faron” or the “Company”)Company announcement, 27 August 2020 at 9.00 AM (EET) TURKU – FINLAND, 27 August 2020 – Faron Pharmaceuticals Ltd (“Faron”) (LON: FARN), the clinical stage biopharmaceutical company, will announce its unaudited half-year report for the six months ended 30 June 2020 on Thursday 24 September 2020. Dr. Markku Jalkanen, Chief Executive Officer, Toni Hänninen, Chief Financial Officer, and Yrjö Wichmann, VP Financing will host a conference call and webcast followed by a Q&A session at 12:30 pm BST (7:30 am EST) to discuss the financial

Lifco issues two bond loans of in total SEK 1,200 million

Lifco  has issued two unsecured bond loans with a tenor of two years within its MTN program (Medium Term Notes). The first bond loan amounts to SEK 1,000 million and carries a floating interest rate of three months STIBOR +1.00% annually. The second bond loan amounts to SEK 200 million and carries a fixed rate of 0.988% annually. The bonds generated strong investor interest. The proceeds from the bond issues will be used for refinancing of existing bank loans. Lifco intends to list the new bonds on the corporate bond list of Nasdaq Stockholm. Danske Bank and SEB

Publication of Interim Report First Half-Year 2020

OSLO, NORWAY – 27 August 2020, CET 08:00 – Zwipe AS today publishes its half-year report for H1 2020. Highlights for first half-year 2020 include: Financials Second Quarter · Second quarter revenues at TNOK 486 (241) · Second quarter result after tax at TNOK -15 842 (-20 989) · Result per share for the second quarter of NOK -0.62 (-1.32) · Cash flow from operations before financing at TNOK -14 789 (-22 554) First Half Year · Total revenues for the first half year TNOK 880 (348) · Result after tax at TNOK -31 590 (-36 329) · Result per share for the first

Investor Report

To view this report in PDF, please click on the following link:  http://www.rns-pdf.londonstockexchange.com/rns/2619X_1-2020-8-26.pdf    RBC Covered Bond Programme Monthly Investor ReportCalculation Date:                          7/31/2020     This report contains informationregarding assets pledged assecurity (the Cover Pool) inrespect of the obligations underthe Covered Bonds issued underRBC's Global Covered BondProgramme as of the indicatedCalculation Date. The compositionof the Cover Pool will change asLoans are added and removed fromthe Cover

3rd Quarter Results

To view the Third Quarter 2020 Earnings Release in PDF, please click on the link below.http://www.rns-pdf.londonstockexchange.com/rns/2624X_1-2020-8-26.pdf     THIRD QUARTER 2020 EARNINGS RELEASE     ROYAL BANK OF CANADA REPORTS THIRD QUARTER 2020 RESULTS  All amounts are in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Our Q3 2020 Report to Shareholders and Supplementary Financial Information are available at: http://www.rbc.com/

Interim Results

27 August 2020 Independent Oil and Gas plc 1H 2020 Interim Results Independent Oil and Gas plc ("IOG" or the "Company") (AIM: IOG.L), the development and production company focused on becoming a substantial UK gas producer, is pleased to present its unaudited interim results for the six months ended 30 June 2020. Operational Highlights · Core Project Phase 1 development maintaining schedule towards First Gas target of Q3 2021 · Field Development Plan ("FDP") approved by the UK Oil and Gas Authority ("OGA") · Extensive design, engineering, procurement and fabrication

Optomed Plc: Half-year financial report, January – June 2020

Optomed Plc         Stock Exchange Release   27 August 2020 at 9.00, Helsinki Optomed Plc: Half-year financial report, January – June 2020 April – June 2020 · Revenue decreased by 32.7 percent to EUR 2,597 (3,858) thousand · Adjusted EBITDA amounted to EUR -325 (85) thousand corresponding to -12.5 (2.2) percent of revenue · The COVID-19 pandemic has negatively affected the Devices segment revenue, whereas the Software segment remains mostly unaffected · Deliveries to our major Chinese customer, which have been on hold since autumn 2019, resumed again in June, and they

Finnair issues EUR 200 million hybrid bond

Finnair Plc             Stock Exchange Release             27 August 2020 at 09.00 a.m. EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Finnair Plc (the “Company”) issues new euro-denominated in aggregate EUR 200 million capital securities (the “New Capital Securities”). The New Capital Securities will bear interest at a fixed interest rate

Best revenue and profit so far

The second quarter: April – The half-year period: January –June June · Net sales increased 8 · Net sales increased 13percent to 352 MSEK (325). percent to 673 MSEK (595). · Order intake amounted to · Order intake amounted to278 MSEK (436). 618 MSEK (798). · Order backlog amounted to · Operating profit increased1,469 MSEK (1,641). 17 percent to 84 MSEK (71). · Operating profit increased · Net profit after tax12 percent to 49 MSEK (44). increased 16 percent to 62 MSEK ·

Zengun Group AB (publ) - INTERIM REPORT FOR THE PERIOD 1 JANUARY TO 30 JUNE 2020

Zengun Group AB started its operations on 24 May 2019 when the company acquired all of the shares in Zengun Group Holding AB (Corp. Reg. No. 559050–0699) and its wholly owned subsidiaries from Segulah Fund V. Financial information for the former group (Zengun Group Holding AB) has been included as a basis for comparison. SECOND QUARTER · Net turnover amounted to MSEK 709.9 (203.3). · EBITDA totalled MSEK 28.7 (7.5), corresponding to an EBITDA margin of 4.0% (3.7). · Ernings before tax amounted to MSEK 13.3. · Operating cash flow was MSEK 62.7 (78.1) FIRST HALF OF THE

Hunter Group ASA - Second Quarter Results 2020

27 August 2020   Financial highlights Total revenues of USD 29.62m − Spot pool revenues of USD 14.78m − Time charter revenues of USD 14.84m Total operating expenses of USD 6.44m − Vessel opex incl. insurance of USD 2.46m − Voyage exp. and commissions of USD 0.33m − G&A expenses of 0.33m − USD 0.19m administrative expenses − USD 0.06m legal expenses − USD 0.08m non-cash expenses EBITDA of USD 26.50m Net profit of USD 18.84m   Average daily earnings of USD 76,340 − Avg. daily spot earnings of USD 75,0001 − Avg. daily time charter earnings

There are no items matching the current filter
There are no more items matching the current filter
Back to top